Notably, the paper also includes simulation studies outlining when dDRTC is most effective, positioning it as a practical ...

The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite.

InflaRx had been pursuing development of vilobelimab in other indications beyond COVID, but the company’s hopes for the asset ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...

AbbVie's Q1 2026 dividend increases 5.5% YOY, lagging both its past growth rates and the healthcare sector median. Learn more ...

Hamad Medical Corporation (HMC) has lined up high impact conferences, workshops and scientific events for 2026, reinforcing ...

Dupilumab, a fully human monoclonal antibody, inhibits the signaling of the interleukin 4 (IL-4) and IL-13 pathways.

AbbVie (NYSE: ABBV). Image source: . AbbVie is a pharmaceutical leader. When it comes to resilient industries, few can exceed ...

Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of ...

Joe and Teresa Graedon answer questions about how to treat leg cramps, uncomfortable digestion, and whether peanut butter protein can transfer via breast milk.

It's been 30 years since a deadly infectious cancer was first detected in the Tasmanian devil, threatening to send the ...